Search

everythinglearnresearchcommunity

for

Search:↓

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Topical minoxidil increases hair density in androgenetic alopecia but has unclear clinical significance.

Composite biodegradable biomaterials can improve diabetic wound healing but need more development for clinical use.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

AI can greatly improve plastic surgery, but ethical care and human aspects must remain a priority.

Inclusive dermatology aims to provide personalized skin care for all by addressing diverse needs and disparities.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Diet can influence inflammatory skin diseases.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Robotic technology in plastic surgery shows promise but needs more research and cost reduction for wider use.

PRP may improve hair transplant results, but more research is needed.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Combined oral minoxidil and finasteride significantly improve hair density in men with male pattern baldness.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Finasteride 1 mg may help prevent prostate issues, but more research is needed to confirm its benefits.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

COC treatment improves hormone and metabolic levels in PCOS patients.

HS needs personalized treatment plans and more research.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Tofacitinib is an effective and safe treatment for alopecia areata.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.